1. Home
  2. DYAI vs MNDO Comparison

DYAI vs MNDO Comparison

Compare DYAI & MNDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYAI
  • MNDO
  • Stock Information
  • Founded
  • DYAI 1979
  • MNDO 1995
  • Country
  • DYAI United States
  • MNDO Israel
  • Employees
  • DYAI N/A
  • MNDO N/A
  • Industry
  • DYAI Biotechnology: Biological Products (No Diagnostic Substances)
  • MNDO EDP Services
  • Sector
  • DYAI Health Care
  • MNDO Technology
  • Exchange
  • DYAI Nasdaq
  • MNDO Nasdaq
  • Market Cap
  • DYAI 35.5M
  • MNDO 34.2M
  • IPO Year
  • DYAI 2004
  • MNDO 2000
  • Fundamental
  • Price
  • DYAI $1.04
  • MNDO $1.48
  • Analyst Decision
  • DYAI Strong Buy
  • MNDO
  • Analyst Count
  • DYAI 1
  • MNDO 0
  • Target Price
  • DYAI $6.00
  • MNDO N/A
  • AVG Volume (30 Days)
  • DYAI 38.3K
  • MNDO 43.0K
  • Earning Date
  • DYAI 05-14-2025
  • MNDO 05-06-2025
  • Dividend Yield
  • DYAI N/A
  • MNDO 15.07%
  • EPS Growth
  • DYAI N/A
  • MNDO N/A
  • EPS
  • DYAI N/A
  • MNDO 0.17
  • Revenue
  • DYAI $3,495,389.00
  • MNDO $20,677,000.00
  • Revenue This Year
  • DYAI $117.40
  • MNDO N/A
  • Revenue Next Year
  • DYAI N/A
  • MNDO N/A
  • P/E Ratio
  • DYAI N/A
  • MNDO $8.61
  • Revenue Growth
  • DYAI 20.58
  • MNDO N/A
  • 52 Week Low
  • DYAI $0.93
  • MNDO $1.43
  • 52 Week High
  • DYAI $2.67
  • MNDO $2.13
  • Technical
  • Relative Strength Index (RSI)
  • DYAI 28.85
  • MNDO 31.76
  • Support Level
  • DYAI $1.05
  • MNDO $1.34
  • Resistance Level
  • DYAI $1.13
  • MNDO $1.49
  • Average True Range (ATR)
  • DYAI 0.07
  • MNDO 0.05
  • MACD
  • DYAI -0.01
  • MNDO -0.01
  • Stochastic Oscillator
  • DYAI 14.29
  • MNDO 40.00

About DYAI Dyadic International Inc.

Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

About MNDO MIND C.T.I. Ltd.

MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.

Share on Social Networks: